Marlowe plc (LON:MRL - Get Free Report)'s stock price was down 0.3% on Monday . The stock traded as low as GBX 318 ($4.03) and last traded at GBX 318 ($4.03). Approximately 435,519 shares were traded during mid-day trading, a decline of 29% from the average daily volume of 613,986 shares. The stock had previously closed at GBX 319 ($4.05).
Analyst Upgrades and Downgrades
Separately, Berenberg Bank restated a "buy" rating and issued a GBX 710 ($9.01) price objective on shares of Marlowe in a report on Wednesday, August 21st.
Get Our Latest Stock Report on MRL
Marlowe Price Performance
The stock has a market cap of £278.92 million, a P/E ratio of -2,271.43 and a beta of 0.44. The company has a debt-to-equity ratio of 58.99, a quick ratio of 0.80 and a current ratio of 1.24. The firm has a 50-day moving average price of GBX 334.56 and a 200-day moving average price of GBX 411.61.
Insider Buying and Selling
In other Marlowe news, insider Peter M. R. Gaze acquired 15,000 shares of the company's stock in a transaction that occurred on Friday, September 27th. The shares were acquired at an average price of GBX 309 ($3.92) per share, with a total value of £46,350 ($58,804.87). 25.30% of the stock is owned by insiders.
Marlowe Company Profile
(
Get Free Report)
Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marlowe, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marlowe wasn't on the list.
While Marlowe currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
